KEGG   PATHWAY: cge05140
Entry
cge05140                    Pathway                                
Name
Leishmaniasis - Cricetulus griseus (Chinese hamster)
Description
Leishmania is an intracellular protozoan parasite of macrophages that causes visceral, mucosal, and cutaneous diseases. The parasite is transmitted to humans by sandflies, where they survive and proliferate intracellularly by deactivating the macrophage. Successful infection of Leishmania is achieved by alteration of signaling events in the host cell, leading to enhanced production of the autoinhibitory molecules like TGF-beta and decreased induction of cytokines such as IL12 for protective immunity. Nitric oxide production is also inhibited. In addition, defective expression of major histocompatibility complex (MHC) genes silences subsequent T cell activation mediated by macrophages, resulting in abnormal immune responses.
Class
Human Diseases; Infectious disease: parasitic
Pathway map
cge05140  Leishmaniasis
cge05140

Organism
Cricetulus griseus (Chinese hamster) [GN:cge]
Gene
100771475  Tlr2; LOW QUALITY PROTEIN: toll-like receptor 2 [KO:K10159]
100689329  Tlr4; toll-like receptor 4 precursor [KO:K10160]
100775060  Myd88; myeloid differentiation primary response protein MyD88 [KO:K04729]
100773909  Irak1; interleukin-1 receptor-associated kinase 1 isoform X6 [KO:K04730] [EC:2.7.11.1]
100751891  Irak4; interleukin-1 receptor-associated kinase 4 isoform X1 [KO:K04733] [EC:2.7.11.1]
100753700  Traf6; TNF receptor-associated factor 6 [KO:K03175] [EC:2.3.2.27]
100774341  Map3k7; mitogen-activated protein kinase kinase kinase 7 isoform X2 [KO:K04427] [EC:2.7.11.25]
100771613  Tab1; TGF-beta-activated kinase 1 and MAP3K7-binding protein 1 [KO:K04403]
100759882  Tab2; TGF-beta-activated kinase 1 and MAP3K7-binding protein 2 [KO:K04404]
100769201  Nfkbib; NF-kappa-B inhibitor beta isoform X2 [KO:K02581]
100754153  Nfkbia; NF-kappa-B inhibitor alpha isoform X2 [KO:K04734]
100770607  Nfkb1; nuclear factor NF-kappa-B p105 subunit isoform X3 [KO:K02580]
100763542  Rela; transcription factor p65 isoform X4 [KO:K04735]
100769260  Il1a; interleukin-1 alpha [KO:K04383]
100775079  Il1b; interleukin-1 beta [KO:K04519]
100760602  Il12a; interleukin-12 subunit alpha [KO:K05406]
100764758  Il12b; interleukin-12 subunit beta [KO:K05425]
100764780  Tnf; tumor necrosis factor isoform X1 [KO:K03156]
100755642  Il4; interleukin-4 [KO:K05430]
100760062  Nos2; nitric oxide synthase, inducible isoform X2 [KO:K13241] [EC:1.14.13.39]
100759320  Il10; interleukin-10 isoform X1 [KO:K05443]
100773359  Tgfb1; transforming growth factor beta-1 proprotein isoform X2 [KO:K13375]
100774918  Tgfb2; transforming growth factor beta-2 proprotein isoform X1 [KO:K13376]
100756831  Tgfb3; transforming growth factor beta-3 proprotein isoform X1 [KO:K13377]
100763958  C3; complement C3 [KO:K03990]
100772783  Cr1l; complement component receptor 1-like protein isoform X3 [KO:K04011]
100758889  Itgam; integrin alpha-M isoform X2 [KO:K06461]
100756135  Itgb2; integrin beta-2 [KO:K06464]
113831736  immunoglobulin heavy variable 3-48 [KO:K06856]
113831730  uncharacterized protein LOC113831730 [KO:K06856]
113838236  uncharacterized protein LOC113838236 [KO:K06856]
100774550  Fcgr1a; high affinity immunoglobulin gamma Fc receptor I [KO:K06498]
103161891  low affinity immunoglobulin gamma Fc region receptor III isoform X1 [KO:K06472]
103161892  low affinity immunoglobulin gamma Fc region receptor IV isoform X2 [KO:K06463]
100762323  Itga4; integrin alpha-4 [KO:K06483]
100763033  Itgb1; integrin beta-1 isoform X2 [KO:K05719]
100751220  Ptgs2; prostaglandin G/H synthase 2 [KO:K11987] [EC:1.14.99.1]
100760922  Prkcb; protein kinase C beta type isoform X2 [KO:K19662] [EC:2.7.11.13]
100769204  Ncf1; neutrophil cytosol factor 1 isoform X2 [KO:K08011]
100767090  Ncf2; neutrophil cytosol factor 2 isoform X1 [KO:K08010]
100773086  Ncf4; neutrophil cytosol factor 4 [KO:K08012]
100760802  cytochrome b-245 heavy chain [KO:K21421] [EC:1.-.-.-]
100766833  cytochrome b-245 light chain [KO:K08009]
100759514  Mapk1; mitogen-activated protein kinase 1 isoform X2 [KO:K04371] [EC:2.7.11.24]
100753149  Mapk3; mitogen-activated protein kinase 3 isoform X2 [KO:K04371] [EC:2.7.11.24]
100763890  Elk1; ETS domain-containing protein Elk-1 [KO:K04375]
100689418  Fos; proto-oncogene c-Fos [KO:K04379]
113834001  transcription factor AP-1 [KO:K04448]
100689104  Mapk14; mitogen-activated protein kinase 14 isoform X3 [KO:K04441] [EC:2.7.11.24]
100759172  Mapk11; mitogen-activated protein kinase 11 isoform X2 [KO:K04441] [EC:2.7.11.24]
100754042  Mapk12; mitogen-activated protein kinase 12 isoform X1 [KO:K04441] [EC:2.7.11.24]
100763519  Mapk13; mitogen-activated protein kinase 13 isoform X2 [KO:K04441] [EC:2.7.11.24]
100768486  Ifng; interferon gamma isoform X2 [KO:K04687]
100772793  Ifngr1; interferon gamma receptor 1 [KO:K05132]
100768877  Ifngr2; interferon gamma receptor 2 isoform X3 [KO:K05133]
100754824  Jak1; tyrosine-protein kinase JAK1 isoform X1 [KO:K11217] [EC:2.7.10.2]
100769337  Jak2; tyrosine-protein kinase JAK2 [KO:K04447] [EC:2.7.10.2]
100755609  Stat1; signal transducer and activator of transcription 1-alpha/beta isoform X1 [KO:K11220]
100750512  H-2 class II histocompatibility antigen, E-S beta chain isoform X2 [KO:K06752]
100759913  RLA class II histocompatibility antigen, DP alpha-1 chain [KO:K06752]
100760208  HLA class II histocompatibility antigen, DO alpha chain [KO:K06752]
100759342  HLA class II histocompatibility antigen, DP beta 1 chain [KO:K06752]
100760794  class II histocompatibility antigen, M alpha chain [KO:K06752]
103161518  HLA class II histocompatibility antigen, DO beta chain [KO:K06752]
100761373  rano class II histocompatibility antigen, A beta chain isoform X2 [KO:K06752]
100752328  H-2 class II histocompatibility antigen, I-E alpha chain [KO:K06752]
100761951  LOW QUALITY PROTEIN: H-2 class II histocompatibility antigen, I-E beta chain-like [KO:K06752]
100766775  LOW QUALITY PROTEIN: H-2 class II histocompatibility antigen, E-S beta chain-like isoform X2 [KO:K06752]
100767068  H-2 class II histocompatibility antigen, E-D beta chain [KO:K06752]
100762240  H-2 class II histocompatibility antigen, E-D beta chain-like isoform X2 [KO:K06752]
100767639  H-2 class II histocompatibility antigen, E-U alpha chain isoform X2 [KO:K06752]
100774703  LOW QUALITY PROTEIN: H-2 class II histocompatibility antigen, E-S beta chain [KO:K06752]
100761082  class II histocompatibility antigen, M beta 1 chain [KO:K06752]
100758743  Marcksl1; MARCKS-related protein isoform X2 [KO:K13536]
103163745  LOW QUALITY PROTEIN: MARCKS-related protein-like [KO:K13536]
100770366  elongation factor 1-alpha 1 [KO:K03231]
100760295  Eef1a2; elongation factor 1-alpha 2 [KO:K03231]
100689276  Eef1a1; elongation factor 1-alpha 1 [KO:K03231]
100758996  Ptpn6; tyrosine-protein phosphatase non-receptor type 6 [KO:K05697] [EC:3.1.3.48]
Compound
C00076  Calcium cation
C00195  N-Acylsphingosine
C00219  Arachidonate
C00533  Nitric oxide
C00584  Prostaglandin E2
C02737  Phosphatidylserine
Reference
  Authors
Cunningham AC
  Title
Parasitic adaptive mechanisms in infection by leishmania.
  Journal
Exp Mol Pathol 72:132-41 (2002)
DOI:10.1006/exmp.2002.2418
Reference
  Authors
Nandan D, Knutson KL, Lo R, Reiner NE
  Title
Exploitation of host cell signaling machinery: activation of macrophage phosphotyrosine phosphatases as a novel mechanism of molecular microbial pathogenesis.
  Journal
J Leukoc Biol 67:464-70 (2000)
DOI:10.1002/jlb.67.4.464
Reference
PMID:7591091
  Authors
Nandan D, Reiner NE
  Title
Attenuation of gamma interferon-induced tyrosine phosphorylation in mononuclear phagocytes infected with Leishmania donovani: selective inhibition of signaling through Janus kinases and Stat1.
  Journal
Infect Immun 63:4495-500 (1995)
DOI:10.1128/IAI.63.11.4495-4500.1995
Reference
  Authors
Nandan D, Lo R, Reiner NE
  Title
Activation of phosphotyrosine phosphatase activity attenuates mitogen-activated protein kinase signaling and inhibits c-FOS and nitric oxide synthase expression in macrophages infected with Leishmania donovani.
  Journal
Infect Immun 67:4055-63 (1999)
DOI:10.1128/IAI.67.8.4055-4063.1999
Reference
PMID:7916951
  Authors
Reiner NE
  Title
Altered cell signaling and mononuclear phagocyte deactivation during intracellular infection.
  Journal
Immunol Today 15:374-81 (1994)
DOI:10.1016/0167-5699(94)90176-7
Reference
  Authors
Nandan D, Reiner NE
  Title
Leishmania donovani engages in regulatory interference by targeting macrophage protein tyrosine phosphatase SHP-1.
  Journal
Clin Immunol 114:266-77 (2005)
DOI:10.1016/j.clim.2004.07.017
Reference
  Authors
Kima PE
  Title
The amastigote forms of Leishmania are experts at exploiting host cell processes to establish infection and persist.
  Journal
Int J Parasitol 37:1087-96 (2007)
DOI:10.1016/j.ijpara.2007.04.007
Reference
  Authors
Forget G, Gregory DJ, Olivier M
  Title
Proteasome-mediated degradation of STAT1alpha following infection of macrophages with Leishmania donovani.
  Journal
J Biol Chem 280:30542-9 (2005)
DOI:10.1074/jbc.M414126200
Reference
  Authors
Cameron P, McGachy A, Anderson M, Paul A, Coombs GH, Mottram JC, Alexander J, Plevin R
  Title
Inhibition of lipopolysaccharide-induced macrophage IL-12 production by Leishmania mexicana amastigotes: the role of cysteine peptidases and the NF-kappaB signaling pathway.
  Journal
J Immunol 173:3297-304 (2004)
DOI:10.4049/jimmunol.173.5.3297
Reference
  Authors
Tuon FF, Amato VS, Bacha HA, Almusawi T, Duarte MI, Amato Neto V
  Title
Toll-like receptors and leishmaniasis.
  Journal
Infect Immun 76:866-72 (2008)
DOI:10.1128/IAI.01090-07
Reference
  Authors
Kropf P, Freudenberg N, Kalis C, Modolell M, Herath S, Galanos C, Freudenberg M, Muller I
  Title
Infection of C57BL/10ScCr and C57BL/10ScNCr mice with Leishmania major reveals a role for Toll-like receptor 4 in the control of parasite replication.
  Journal
J Leukoc Biol 76:48-57 (2004)
DOI:10.1189/jlb.1003484
Reference
  Authors
Feng GJ, Goodridge HS, Harnett MM, Wei XQ, Nikolaev AV, Higson AP, Liew FY
  Title
Extracellular signal-related kinase (ERK) and p38 mitogen-activated protein (MAP) kinases differentially regulate the lipopolysaccharide-mediated induction of inducible nitric oxide synthase and IL-12 in macrophages: Leishmania phosphoglycans subvert macrophage IL-12 production by targeting ERK MAP kinase.
  Journal
J Immunol 163:6403-12 (1999)
Reference
  Authors
Olivier M, Gregory DJ, Forget G
  Title
Subversion mechanisms by which Leishmania parasites can escape the host immune response: a signaling point of view.
  Journal
Clin Microbiol Rev 18:293-305 (2005)
DOI:10.1128/CMR.18.2.293-305.2005
Reference
  Authors
Matte C, Maion G, Mourad W, Olivier M
  Title
Leishmania donovani-induced macrophages cyclooxygenase-2 and prostaglandin E2 synthesis.
  Journal
Parasite Immunol 23:177-84 (2001)
DOI:10.1046/j.1365-3024.2001.00372.x
Reference
  Authors
Ghosh S, Bhattacharyya S, Sirkar M, Sa GS, Das T, Majumdar D, Roy S, Majumdar S
  Title
Leishmania donovani suppresses activated protein 1 and NF-kappaB activation in host macrophages via ceramide generation: involvement of extracellular signal-regulated kinase.
  Journal
Infect Immun 70:6828-38 (2002)
DOI:10.1128/IAI.70.12.6828-6838.2002
Reference
PMID:9504340
  Authors
Bogdan C, Rollinghoff M
  Title
The immune response to Leishmania: mechanisms of parasite control and evasion.
  Journal
Int J Parasitol 28:121-34 (1998)
DOI:10.1016/S0020-7519(97)00169-0
Reference
  Authors
Blanchette J, Abu-Dayyeh I, Hassani K, Whitcombe L, Olivier M
  Title
Regulation of macrophage nitric oxide production by the protein tyrosine phosphatase Src homology 2 domain phosphotyrosine phosphatase 1 (SHP-1).
  Journal
Immunology 127:123-33 (2009)
DOI:10.1111/j.1365-2567.2008.02929.x
Reference
  Authors
Alexander J, Satoskar AR, Russell DG
  Title
Leishmania species: models of intracellular parasitism.
  Journal
J Cell Sci 112 Pt 18:2993-3002 (1999)
Reference
  Authors
Denkers EY, Butcher BA
  Title
Sabotage and exploitation in macrophages parasitized by intracellular protozoans.
  Journal
Trends Parasitol 21:35-41 (2005)
DOI:10.1016/j.pt.2004.10.004
Reference
  Authors
Lodge R, Diallo TO, Descoteaux A
  Title
Leishmania donovani lipophosphoglycan blocks NADPH oxidase assembly at the phagosome membrane.
  Journal
Cell Microbiol 8:1922-31 (2006)
DOI:10.1111/j.1462-5822.2006.00758.x
Reference
  Authors
de Freitas Balanco JM, Moreira ME, Bonomo A, Bozza PT, Amarante-Mendes G, Pirmez C, Barcinski MA
  Title
Apoptotic mimicry by an obligate intracellular parasite downregulates macrophage microbicidal activity.
  Journal
Curr Biol 11:1870-3 (2001)
DOI:10.1016/S0960-9822(01)00563-2
Reference
  Authors
Kane MM, Mosser DM
  Title
Leishmania parasites and their ploys to disrupt macrophage activation.
  Journal
Curr Opin Hematol 7:26-31 (2000)
DOI:10.1097/00062752-200001000-00006
Reference
  Authors
de Almeida MC, Vilhena V, Barral A, Barral-Netto M
  Title
Leishmanial infection: analysis of its first steps. A review.
  Journal
Mem Inst Oswaldo Cruz 98:861-70 (2003)
DOI:10.1590/S0074-02762003000700001
Related
pathway
cge00590  Arachidonic acid metabolism
cge04010  MAPK signaling pathway
cge04020  Calcium signaling pathway
cge04120  Ubiquitin mediated proteolysis
cge04145  Phagosome
cge04610  Complement and coagulation cascades
cge04620  Toll-like receptor signaling pathway
cge04630  JAK-STAT signaling pathway
cge04666  Fc gamma R-mediated phagocytosis
KO pathway
ko05140   

DBGET integrated database retrieval system